• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advanced Practice Providers and Buprenorphine Access in the United States After the Comprehensive Addiction and Recovery Act.

作者信息

Lee Dennis, Saloner Brendan, Barnett Michael

机构信息

Department of Health Policy, Vanderbilt University, Nashville (Lee);Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore (Saloner); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett)Department of Psychiatry, University of Southern California, Los Angeles (Oh);Department of Public Health, Wayne State University, Detroit (Zhou);Milken Institute School of Public Health, George Washington University, Washington, D.C. (Banawa)Center for Mental Health, Department of Psychiatry(Shields, Marcus), Leonard Davis Institute of Health Economics (Shields, Marcus, Chatterjee), School of Social Policy and Practice (Marcus), and Department of Medicine (Chatterjee), University of Pennsylvania, Philadelphia; Center for Mental Health and Addiction Policy, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore (Hollander)UTHealth Harris County Psychiatric Center, Louis A. Fallace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, HoustonBernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, Virginia.

出版信息

Psychiatr Serv. 2021 Nov 1;72(11):1358-1359. doi: 10.1176/appi.ps.202100122.

DOI:10.1176/appi.ps.202100122
PMID:34734748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10163959/
Abstract
摘要

相似文献

1
Advanced Practice Providers and Buprenorphine Access in the United States After the Comprehensive Addiction and Recovery Act.《综合成瘾与康复法案》之后美国的高级执业提供者与丁丙诺啡获取情况
Psychiatr Serv. 2021 Nov 1;72(11):1358-1359. doi: 10.1176/appi.ps.202100122.
2
Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.丁丙诺啡供应、可及性和质量：我们已经取得的成就和前进的道路。
J Law Med Ethics. 2018 Jun;46(2):272-278. doi: 10.1177/1073110518782934.
3
Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019.2016年至2019年美国持有丁丙诺啡豁免权的医疗服务提供者数量增加。
Psychiatr Serv. 2020 Sep 1;71(9):971. doi: 10.1176/appi.ps.201900635. Epub 2020 May 28.
4
Using buprenorphine to treat patients with opioid use disorder.使用丁丙诺啡治疗阿片类物质使用障碍患者。
JAAPA. 2019 Oct;32(10):30-35. doi: 10.1097/01.JAA.0000580544.64346.d7.
5
Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.2007 - 2017年美国丁丙诺啡豁免处方医生的增长与分布情况
Ann Intern Med. 2020 Apr 7;172(7):504-506. doi: 10.7326/M19-2403. Epub 2020 Jan 7.
6
The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?处方所需数量——扩大丁丙诺啡可及性需要什么？
N Engl J Med. 2021 May 13;384(19):1783-1784. doi: 10.1056/NEJMp2101298. Epub 2021 May 8.
7
The prescribing of buprenorphine by advanced practice addictions nurses.成瘾专科高级执业护士开具丁丙诺啡的情况。
J Addict Nurs. 2012 Feb;23(1):82-3. doi: 10.3109/10884602.2011.649026.
8
Use of Buprenorphine to Treat Opioid Use Disorder.使用丁丙诺啡治疗阿片类物质使用障碍。
J Psychosoc Nurs Ment Health Serv. 2018 Nov 1;56(11):9-12. doi: 10.3928/02793695-20181012-02.
9
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.
10
Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.为何24位州和领地卫生官员支持丁丙诺啡管制放松。
Am J Public Health. 2019 Dec;109(12):1678-1679. doi: 10.2105/AJPH.2019.305370.

引用本文的文献

1
Changes in legal referrals to specialty substance use disorder treatment from 2015-2019.2015年至2019年期间转介至专门物质使用障碍治疗机构的法律转介情况变化。
Health Justice. 2024 Nov 6;12(1):42. doi: 10.1186/s40352-024-00297-2.
2
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies.美国社区药房中经济和种族隔离与丁丙诺啡配药受限的关联。
Drug Alcohol Depend Rep. 2024 Jul 14;12:100255. doi: 10.1016/j.dadr.2024.100255. eCollection 2024 Sep.
3
Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.阿片类物质使用障碍治疗中大量开处丁丙诺啡处方医生的重要性日益增加：2009-2018 年。
Drug Alcohol Depend. 2024 Jun 1;259:111290. doi: 10.1016/j.drugalcdep.2024.111290. Epub 2024 Apr 16.
4
National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018.2007 年至 2018 年阿片类药物使用障碍布比卡因治疗的国家趋势。
Subst Abus. 2023 Jul;44(3):154-163. doi: 10.1177/08897077231179576. Epub 2023 Jun 6.

本文引用的文献

1
In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.自 2017 年以来，农村地区通过护士从业者和医师助理采用丁丙诺啡豁免疫。
Health Aff (Millwood). 2019 Dec;38(12):2048-2056. doi: 10.1377/hlthaff.2019.00859.
2
Primary Care Nurse Practitioners and Physicians in Low-Income and Rural Areas, 2010-2016.2010-2016 年，低收入和农村地区的初级保健护士从业者和医生。
JAMA. 2019 Jan 1;321(1):102-105. doi: 10.1001/jama.2018.17944.